Skip to main content

Table 1 Characteristics of the patients

From: The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS)

Factors

Category

Total number of cases

Number of progressive cases

Number of death cases

Age

< 60

23

10

5

\(\ge\) 60

8

5

4

Ann Arbor staging

Stage I–II

10

1

1

Stage III–IV

21

14

8

IPI Score

Low risk

17

3

1

(0–2 points)

   

High risk

14

12

8

(3–4 points)

   

SUVmax

< 7.28

14

5

2

\(\ge\) 7.28

17

10

7

MTV (cm\(^3\))

< 158.16

15

3

1

\(\ge\) 158.16

16

12

8

D-5PS Score

< 4-Point

21

6

4

\(\ge\) 4-Point

10

9

5